Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals a randomized controlled experimental medicine study

Archives of General Psychiatry

Volumn 67, Issue 10, 2010, Pages 1069-1077

  Umhau, John C ^a   Momenan, Reza ^a   Schwandt, Melanie L ^a   Singley, Erick ^a   Lifshitz, Mariel ^a   Doty, Linda ^a   Adams, Lauren J ^a   Vengeliene, Valentina ^b   Spanagel, Rainer ^b   Zhang, Yan ^c   Shen, Jun ^c   George, David T ^a   Hommer, Daniel ^a   Heilig, Markus ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALCOHOL; BENZODIAZEPINE; CHOLINE; CORTICOTROPIN RELEASING FACTOR; CREATINE; DEXAMETHASONE; GLUTAMIC ACID; HYDROCORTISONE; N ACETYLASPARTIC ACID; PLACEBO; DRUGS USED IN THE TREATMENT OF ADDICTION; GLUCOCORTICOID; TAURINE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL BLOOD LEVEL; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BRAIN METABOLISM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HOSPITAL PATIENT; HUMAN; LIQUID CHROMATOGRAPHY; LOADING DRUG DOSE; MALE; NEUROIMAGING; NEUROTRANSMISSION; PATIENT COMPLIANCE; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; CINGULATE GYRUS; DIAGNOSTIC USE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ALCOHOL DETERRENTS; ALCOHOLISM; CORTICOTROPIN-RELEASING HORMONE; CREATINE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; GLUTAMIC ACID; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; TAURINE;

EID: 77957690685     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2010.125     Document Type: Article

References (45)

1. Tsai G, Coyle JT. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med. 1998;49:173-184.
2. Spanagel R, Kiefer F. Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol Sci. 2008;29(3):109-115.
3. De Witte P, Pinto E, Ansseau M, Verbanck P. Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev. 2003;27(3):189-197. (Pubitemid 36677428)
4. Spanagel R. Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev. 2009;89(2):649-705.
5. Dahchour A, De Witte P. Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods. Alcohol Clin Exp Res. 2003;27(3):465-470.
6. Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron. 2002;35(4):605-623.
7. Nestler EJ. Molecular neurobiology of addiction. Am J Addict. 2001;10(3):201-217.
8. Rimondini R, Arlinde C, Sommer W, Heilig M. Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J. 2002;16(1):27-35.
9. Flatscher-Bader T, Wilce PA. Chronic smoking and alcoholism change expression of selective genes in the human prefrontal cortex. Alcohol Clin Exp Res. 2006;30(5):908-915.
10. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 1996;16(3):675-686. (Pubitemid 26103145)
11. Mason BJ, Ownby RL. Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo-controlled trials. CNS Spectr. 2000;5(2):58-69.
12. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003-2017.
13. Mann K, Lehert P, Morgan MY. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res. 2004;28(1):51-63.
14. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC, Lascorz J, Depner M, Holzberg D, Soyka M, Schreiber S, Matsuda F, Lathrop M, Schumann G, Albrecht U. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med. 2005;11(1):35-42.
15. Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 2000;47(4):305-313.
16. Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U, Wolgast M, Fiebich M, Arolt V, Heindel W. Effective electroconvulsive therapy reverses glutamate/ glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res. 2003;122(3):185-192. (Pubitemid 36412193)
17. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2007;64(2):193-200. (Pubitemid 46220776)
18. Bolo N, Nédélec JF, Muzet M, De Witte P, Dahchour A, Durbin P, Macher JP. Central effects of acamprosate, part 2: acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers. Psychiatry Res. 1998;82(2):115-127.
19. Mason GF, Petrakis IL, de Graaf RA, Gueorguieva R, Guidone E, Coric V, Epperson CN, Rothman DL, Krystal JH. Cortical γ-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry. 2006;59(1):85-93.
20. Hurd R, Sailasuta N, Srinivasan R, Vigneron DB, Pelletier D, Nelson SJ. Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med. 2004;51(3):435-440.
21. Liu J, Yu BJ, Neugebauer V, Grigoriadis DE, Rivier J, Vale WW, Shinnick- Gallagher P, Gallagher JP. Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission. J Neurosci. 2004;24(16):4020-4029.
22. Heuser I, Yassouridis A, Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res. 1994;28(4):341-356. (Pubitemid 24370022)
23. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment of Alcohol Scale (CIWA-Ar). Br J Addict. 1989;84(11):1353-1357.
24. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version. Washington, DC: American Psychiatric Press; 1997.
25. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199-213.
26. Skinner H, Horn J. Alcohol Dependence Scale: User's Guide. Toronto, Ontario, Canada: Addiction Research Foundation; 1984.
27. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing selfreported alcohol consumption. In: Litten RZ, Allen JP, eds. Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Totowa, NJ: Humana Press; 1992:41-72.
28. Svanborg P, Asberg M. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand. 1994;89(1):21-28.
29. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213.
30. Sullivan EV, Pfefferbaum A. Neurocircuitry in alcoholism: a substrate of disruption and repair. Psychopharmacology (Berl). 2005;180(4):583-594.
31. Umhau JC, Petrulis SG, Diaz R, Rawlings R, George DT. Blood glucose is correlated with cerebrospinal fluid neurotransmitter metabolites. Neuroendocrinology. 2003;78(6):339-343. (Pubitemid 38037049)
32. Cohen SA, Michaud DP. Synthesis of a fluorescent derivatizing reagent, 6-aminoquinolyl- N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography. Anal Biochem. 1993;211(2):279-287.
33. Rydmark I, Wahlberg K, Ghatan PH, Modell S, Nygren A, Ingvar M, Asberg M, Heilig M. Neuroendocrine, cognitive and structural imaging characteristics of women on longterm sickleave with job stress-induced depression. Biol Psychiatry. 2006;60(8):867-873.
34. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health. 1996;86(5):726-728.
35. Bartsch AJ, Homola G, Biller A, Smith SM, Weijers HG, Wiesbeck GA, Jenkinson M, De Stefano N, Solymosi L, Bendszus M. Manifestations of early brain recovery associated with abstinence from alcoholism. Brain. 2007;130(pt 1):36-47. (Pubitemid 46026221)
36. Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol. 1998;56(4):385-431.
37. Gual A, Lehert P. Acamprosate during and after acute alcohol withdrawal: a doubleblind placebo-controlled study in Spain. Alcohol Alcohol. 2001;36(5):413-418.
38. Staner L, Boeijinga P, Danel T, Gendre I, Muzet M, Landron F, Luthringer R. Effects of acamprosate on sleep during alcohol withdrawal: a double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Alcohol Clin Exp Res. 2006;30(9):1492-1499.
39. Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 2000;32(1):1-14.
40. Obernier JA, Bouldin TW, Crews FT. Binge ethanol exposure in adult rats causes necrotic cell death. Alcohol Clin Exp Res. 2002;26(4):547-557.
41. Obernier JA, White AM, Swartzwelder HS, Crews FT. Cognitive deficits and CNS damage after a 4-day binge ethanol exposure in rats. Pharmacol Biochem Behav. 2002;72(3):521-532.
42. Nixon PF. Glutamate export at the choroid plexus in health, thiamin deficiency, and ethanol intoxication: review and hypothesis. Alcohol Clin Exp Res. 2008;32(8):1339-1349.
43. Hundt W, Zimmermann U, Pöttig M, Spring K, Holsboer F. The combined dexamethasone- suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Alcohol Clin Exp Res. 2001;25(5):687-691. (Pubitemid 32448628)
44. Heilig M, Koob GF. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 2007;30(8):399-406.
45. Zimmerman U, Spring K, Koller G, Holsboer F, Soyka M. Hypothalamic-pituitaryadrenal system regulation in recently detoxified alcoholics is not altered by one week of treatment with acamprosate. Pharmacopsychiatry. 2004;37(3):98-102.